All Articles

In May 2019, the FDA approved Tibsovo for the treatment of older patients with newly diagnosed acute myeloid leukemia (AML) and an IDH1 mutation, or for patients with AML who are unable to use intensive chemotherapy. Read More ›

In May 2019, the FDA approved Piqray (alpelisib), the first PI3K inhibitor for the treatment of metastatic breast cancer with a PI3KCA mutation in postmenopausal women, and in men. An FDA spokesperson said it was the first treatment “to demonstrate a clinically meaningful benefit” for this type of breast cancer. Read More ›

In February 2019, the FDA issued a letter to raise awareness of the risk for a rare type of lymphoma, BIA-ALCL, that is linked to all types of breast implants. Although this is an uncommon reaction to implants, all women who have or intend to get an implant after breast cancer should be aware of this risk. Learn more about this risk here. Read More ›

Many false notions about cancer circulate online and among patients and their family members and friends. These myths often are not based on scientific evidence and may prevent people from receiving best treatments or add misplaced anxiety. Dr. Pankaj Vashi debunks some of these common myths. Read More ›

Therese Verner created this painting when her daughter had breast cancer. Now its positive message of healing helps Therese again as she undergoes her own treatment for breast cancer. Read More ›

In April 2019, the FDA approved Balversa, an FGFR kinase inhibitor, for the treatment of adults with advanced or metastatic bladder cancer and an FGFR genetic alteration, as determined by an FDA-approved diagnostic test. This is the first FDA-approved targeted drug for patients with this specific genetic mutation. Read More ›

In June 2019, the FDA announced a new program called “Project Facilitate” that is designed exclusively for patients with advanced cancer who have exhausted all available treatment options and are unable to participate in clinical trials. Through this program, the FDA will assist doctors and patients to overcome barriers to accessing experimental cancer drugs. Read More ›

After the shock of being diagnosed with advanced-stage brain cancer, oncology nurse Sherry Moore’s outlook on life and her approach to her patients changed profoundly. She also learned that it was okay to be happy, angry, sad, or scared, and that grief was fluid. Read More ›

Genetics play an important role in cancer treatments today. Working with genetic counselors helps to determine if a patient’s cancer has a genetic component, which will influence treatment decisions. Genetic counselor Megan Mortenson explains how genetic counseling may help you or your loved one. Read More ›

After being diagnosed with metastatic adenocarcinoma of the esophagus in 2017, Stephen C. Aldrich realized his treatment options were limited to improving his quality of life but not extending his life. Determined to find a better option, he embarked on a mission to get his data to help design a new vaccine that resulted in his cancer remission. Read his story to find out why all patients with cancer should gain direct control over their data to identify the best treatment options for them. Read More ›